SG10201911421VA - Compositions and methods for protein expression and delivery - Google Patents
Compositions and methods for protein expression and deliveryInfo
- Publication number
- SG10201911421VA SG10201911421VA SG10201911421VA SG10201911421VA SG10201911421VA SG 10201911421V A SG10201911421V A SG 10201911421VA SG 10201911421V A SG10201911421V A SG 10201911421VA SG 10201911421V A SG10201911421V A SG 10201911421VA SG 10201911421V A SG10201911421V A SG 10201911421VA
- Authority
- SG
- Singapore
- Prior art keywords
- delivery
- compositions
- methods
- protein expression
- protein
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5169—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Optics & Photonics (AREA)
- Nanotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Inorganic Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662405613P | 2016-10-07 | 2016-10-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201911421VA true SG10201911421VA (en) | 2020-02-27 |
Family
ID=61831159
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201911421VA SG10201911421VA (en) | 2016-10-07 | 2017-10-06 | Compositions and methods for protein expression and delivery |
| SG11201902945SA SG11201902945SA (en) | 2016-10-07 | 2017-10-06 | Compositions and methods for protein expression and delivery |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201902945SA SG11201902945SA (en) | 2016-10-07 | 2017-10-06 | Compositions and methods for protein expression and delivery |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11510881B2 (en) |
| EP (1) | EP3523321A4 (en) |
| JP (1) | JP7096239B2 (en) |
| KR (1) | KR102579209B1 (en) |
| CN (1) | CN110023328B (en) |
| IL (1) | IL265831A (en) |
| SG (2) | SG10201911421VA (en) |
| WO (1) | WO2018067075A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019092481A (en) * | 2017-11-27 | 2019-06-20 | 国立大学法人東京工業大学 | Hetero protein cage |
| JP2019193594A (en) * | 2018-05-01 | 2019-11-07 | 国立大学法人東京工業大学 | Fusion proteins and uses thereof |
| WO2021045210A1 (en) * | 2019-09-05 | 2021-03-11 | 味の素株式会社 | Ferritin enclosing peptide |
| CN112094861B (en) * | 2020-10-26 | 2022-11-22 | 南京林业大学 | Expression and purification method of green alga plant ferritin and application thereof |
| WO2024043836A1 (en) * | 2022-08-25 | 2024-02-29 | National University Of Singapore | Gastrointestinal tract stabilized protein delivery using disulfide tes system |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7033613B2 (en) * | 2001-05-14 | 2006-04-25 | Matsushita Electric Industrial Co., Ltd. | Recombinant cage-like protein, method for producing the same, precious metal-recombinant cage-like protein complex, method for producing the same and recombinant DNA |
| EP3197920B1 (en) * | 2014-09-25 | 2021-01-13 | Nanyang Technological University | Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages |
| CN107405393A (en) * | 2015-01-29 | 2017-11-28 | 新加坡科技研究局 | Carry the Nano capsule of datum hole Kenya related peptide |
-
2017
- 2017-10-06 CN CN201780073646.4A patent/CN110023328B/en active Active
- 2017-10-06 JP JP2019518924A patent/JP7096239B2/en active Active
- 2017-10-06 US US16/340,089 patent/US11510881B2/en active Active
- 2017-10-06 SG SG10201911421VA patent/SG10201911421VA/en unknown
- 2017-10-06 SG SG11201902945SA patent/SG11201902945SA/en unknown
- 2017-10-06 KR KR1020197012269A patent/KR102579209B1/en active IP Right Grant
- 2017-10-06 EP EP17858829.9A patent/EP3523321A4/en active Pending
- 2017-10-06 WO PCT/SG2017/050505 patent/WO2018067075A1/en unknown
-
2019
- 2019-04-04 IL IL265831A patent/IL265831A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018067075A1 (en) | 2018-04-12 |
| EP3523321A4 (en) | 2020-07-08 |
| EP3523321A1 (en) | 2019-08-14 |
| US11510881B2 (en) | 2022-11-29 |
| KR20190062483A (en) | 2019-06-05 |
| CN110023328B (en) | 2024-03-05 |
| KR102579209B1 (en) | 2023-09-15 |
| IL265831A (en) | 2019-06-30 |
| JP7096239B2 (en) | 2022-07-05 |
| JP2019534700A (en) | 2019-12-05 |
| CN110023328A (en) | 2019-07-16 |
| US20210113484A1 (en) | 2021-04-22 |
| SG11201902945SA (en) | 2019-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL262321A (en) | Compositions and methods for selective protein expression | |
| HK1258900A1 (en) | Delivery methods and compositions | |
| IL268788A (en) | Compositions and methods for enhanced gene expression | |
| HK1253306A1 (en) | Anti-ntb-a antibodies and related compositions and methods | |
| EP3273944A4 (en) | Compositions and methods for delivery of biomacromolecule agents | |
| PT3240895T (en) | Compositions and methods for protein glycosylation | |
| IL283280A (en) | Bacteria-based protein delivery | |
| SG11201704010UA (en) | Fibroin-derived protein composition | |
| HK1256138A1 (en) | Bacteria-based protein delivery | |
| IL265831A (en) | Compositions and methods for protein expression and delivery | |
| IL258570A (en) | Stable protein compositions | |
| GB2546439B (en) | Ezrin-derived peptides and pharmaceutical compositions thereof | |
| EP3288542A4 (en) | Compositions and methods for administering antibodies | |
| PL3072529T3 (en) | Composition comprising vemurafenib and hpmc-as | |
| AU2015901533A0 (en) | Compositions and methods for administering antibodies |